This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $5,372.90 firm-fixed-price contract is for the delivery of "PROQUAD VIALS", a medical product, with a completion date of February 19, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,711.62, is for the delivery of PROQUAD VIALS medical supplies. The contract has an ultimate completion date of November 15, 2024 and was awarded on October 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,601.99 firm fixed price contract is for the delivery of PROQUAD VIALS, a pharmaceutical product. The award has an ultimate completion date of August 23, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,670.90, is for the procurement of PROQUAD VIALS, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,687.44, is for the supply of PROQUAD VIALS, a medical product, under a Firm Fixed Price contract type. The award has an Ultimate Completion Date of March 12, 2025 and was made on February 19, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a ceiling value of $1,601.99 and a performance period through April 11, 2024. This delivery order is part of a larger indefinite delivery contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,687.48, is for the delivery of PROQUAD VIALS, a medical product, to support federal healthcare programs. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any set-aside designation for this award. Additionally, the...
This is a $3,308.68 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PROQUAD VIALS, a medical product, with a period of performance through March 12, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical as a primary...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of PROQUAD vials, a pharmaceutical product, with a potential value of $4,159.95 and a completion date of March 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,247.58, is for the delivery of PROQUAD VIALS and has an ultimate completion date of January 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...